Robert Tighe is a seasoned professional in the field of preclinical and translational sciences, currently serving as Senior Vice President at Ottimo Pharma since February 2025. Prior to this role, Tighe was the Chief Scientific Officer at Ankyra Therapeutics from July 2023 to February 2025. Tighe's experience includes roles as Vice President of Research and VP of Translational Research at TCR² Therapeutics Inc. from July 2019 to June 2023, and Vice President of Translational Immunology & Immunopharmacology at Compass Therapeutics LLC from December 2015 to June 2019. Tighe's earlier career includes significant positions at EMD Serono, Inc., ArQule, The Jackson Laboratory, MIT, and the Whitehead Institute, contributing to advancements in immunology and gene therapy, including co-authoring a notable Science article on sickle cell anemia treatment.
This person is not in the org chart
This person is not in any teams
This person is not in any offices